隔夜美股 | 三大指數跌超1%，疫苗股Arbutus(ABUS.US)升119.86%
週四，美國上周新申領失業救濟人數近4個月來首次上升，投資者擔心新一輪衛生事件進一步打擊就業市場及經濟，拖累美股市場氣氛。美股今日低開，市中在科技股拖累下，道指一度跌超400點。
截至收市，道瓊斯指數跌353.51點，跌幅1.31%，報26652.33點；標普500指數跌39.92點，跌幅1.22%，報3236.10點；納斯達克綜合指數跌244.71點，跌幅2.29%，報10461.42點。
資料及消息面上，美國勞工部報告稱，美國上周首次申領失業救濟人數141.6萬人，創3周新高，預期130萬人，上周為130萬人。截至7月11日當周的續請失業金人數連續第6周回落。機構評論稱，上周美國初請失業金人數近四個月來首次上升，表明由於衛生事件感染病例再度增加和需求低迷，勞動力市場正在停滯。
美國共和黨可能公佈其新一輪刺激方案。據報導，參議院共和黨議員已解決與特朗普政府的分歧，並最早有望在今天公佈其新一輪刺激方案。不過，尚不清楚該方案是否納入了特朗普政府提出的減免工資稅的政策以及對現行失業救濟金的削減幅度。
市面上，科技股普跌。蘋果(AAPL.US)跌超4%，特斯拉(TSLA.US)跌約5%、競爭對手Nikola(NKLA.US)也跌超6%，微軟(MSFT.US)跌超4%，社交媒體Facebook(FB.US)、谷歌A(GOOGL.US)、以及電商亞馬遜(AMZN.US)均跌超3%。
個股方面
Arbutus(ABUS.US)升119.86%、Moderna(MRNA.US)跌9.49%，Moderna與Arbutus公司在一項疫苗專利糾紛案中失利，美國專利審查與上訴委員會認為Arbutus可用于開發疫苗相關技術的專利依然有效；
推特(TWTR.US)升4.03%, 公司二季度營收6.834億美元，市場預期7.07億美元，同比下降18.77%，二季度mDAU同比增長34%；
美國銀行(BAC.US)升0.9%，巴菲特在週一至週三以平均每股24美元的價格買入近3400萬股該公司股票，價值8.13億美元；
西南航空(LUV.US)收跌1.56%，第二季度營收同比下滑83%；
黑石集團(BX.US)收跌2.31%，二季度營收25.2億美元，同比增長68%。淨利潤為13.54億美元，上年同期為6.47億美元；
Ascena(ASNA.US)跌25.7%，該公司已申請破產保護，將永久關閉其在加拿大、波多黎各和墨西哥的所有品牌門店。
王道科技(EDTK.US)首日上市，收跌5%，報4.75美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
